From a unique tumor microenvironment that favors the growth and survival of GBM cells to the usage of immune checkpoint molecules such as PD-L1, CTLA-4, and T-cell Ig and mucin domain 3 (TIM-3), GBM thrives and develops explaining its characteristic high replication. This evidence concerns the gene HAVCR2 and glioblastoma.